Search results
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 2 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 7 hours agoAt the same time, the company is under pressure to develop an even more potent anti-obesity drug as...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 2 days agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Novo’s Blockbuster Obesity Drug Wegovy Under Fire in Denmark
Bloomberg· 20 hours agoA Danish drug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s...
Weight Loss Drugs Like Wegovy and Ozempic May Change Sense of Taste
Prevention via Yahoo News· 20 hours agoWeight loss drugs like Wegovy and Ozempic may change sense of taste and how the brain reacts to...
Anti-obesity drugs will be 2024’s defining trend
Clinical Trials Arena via Yahoo Finance· 2 days agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence, and cell and gene therapies.
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 2 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Thousands in one state to lose weight loss drug coverage
Newsweek· 17 hours agoThousands of people in Michigan who use popular weight loss drugs will soon lose their coverage for...
Is Ozempic an Obesity Drug, or an Everything Drug?
The Atlantic· 3 days agoThere’s no such thing as a miracle cure for weight loss, but the latest obesity drugs seem to come pretty close. People who take Ozempic or other weekly...
8 ways to use behavioral science to address obesity
BenefitsPRO· 14 hours agoEmployers are enthusiastic that effective new drugs to address obesity are now available but are distraught by their exceptionally high-cost impact. The GLP-1 class of < ...